Partners, Collaborators and Investors

Iscaffpharma provides a cost-effective platform to improve success rate in clinical development of treatments for aggressive cancer

Partner with us!

Iscaffpharma will partner with pharmaceutical companies based on co-development and license agreements. We will:

  • License and sell 3D printed scaffolds, with the possibilty of support for analyses
  • Offer verification of 3D results in human scaffolds
  • Offer target and drug screening

In addition, we will develop our own cancer drug portfolio based on the platform. Our main Focus is on solid cancer:

  • Breast
  • Colon
  • Ovarian
  • Orphan
  • Moving in to other forms

Iscaffpharma will seek partnerships for commercialization of NCEs from our own portfolio.
We will develop our technology as a cost-effective platform to improve success rate in clinical development of treatments for aggressive cancer.

Contact contact@iscaffpharma.com for more information

Partners, Collaborators and Investors

Iscaffpharma is part of UDI3 challenge driven innovation supported by Vinnova. Our partners are:

vgregunivhosp_o-01
1593648_guv.rgb_
skanes-universitetssjukhus-logga
tataa_logo_liggande_a4_cmyk_300dpi
vinnova_green_payoff_en_rgb
1514062_sacancercenter-kopia
cellprotect-pharmaceuticals
bioinvent
respiratorius-logo03-black-200712
logueng_cen2r
fullsizeoutput_116f
rise_logo_rgb_dr44mov
oblique
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt